Clinical trial

Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus

NCT07373392

Study summary

ClinicalTrials.gov

Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Lactobacillus plantarum ECGC 13110402 Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-01-25

PhaseNA

Conditions

Diabete Type 1unresolved

Diabete Type 2unresolved

Prediabetesverified · MONDO: prediabetes syndrome

Interventions

Lactobacillus plantarum ECGC 13110402DIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Aalborg Universitylead sponsor

Steno Diabetes Center Nordjyllandcollaborator

ProBiotix Health Plc.collaborator

Mapped research locations

GistrupDenmark2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07373392 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.